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BDNF and nitric oxide signaling both contribute to plasticity at glutamatergic synapses.
However, the role of combined signaling of both pathways at the same synapse is
largely unknown. Using NO imaging with diaminofluoresceine in cultured hippocampal
neurons we analyzed the time course of neurotrophin-induced NO signals. Application
of exogenous BDNF, NT-4, and NT-3 (but not NGF) induced NO signals in the
soma and in proximal dendrites of hippocampal neurons that were sensitive to NO
synthase activity, TrkB signaling, and intracellular calcium elevation. The effect of NO
signaling on neurotrophin secretion was analyzed in BDNF-GFP, and NT-3-GFP transfected
hippocampal neurons. Exogenous application of the NO donor sodium-nitroprusside
markedly inhibited neurotrophin secretion. However, endogenously generated NO in
response to depolarization and neurotrophin stimulation, both did not result in a negative
feedback on neurotrophin secretion. These results suggest that a negative feedback of NO
signaling on synaptic secretion of neurotrophins operates only at high intracellular levels of
nitric oxide that are under physiological conditions not reached by depolarization or BDNF
signaling.
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INTRODUCTION
Activity-dependent synaptic plasticity, and especially long-term
potentiation (LTP), is considered as the cellular correlate of learn-
ing and memory processes in the mammalian brain. Extracellular
synaptic messengers, like nitric oxide (NO), and brain-derived
neurotrophic factor (BDNF) are important intercellular signal-
ing molecules mediating some forms of LTP (Hawkins et al.,
1998; reviewed in Hopper and Garthwaite, 2006; Gottmann et al.,
2009; Edelmann et al., 2014). Both NO and BDNF are discussed
as potential retrograde messengers of LTP in the CA1 region
of the hippocampus (see e.g., Hawkins et al., 1998; Lessmann
et al., 2011) and in various cortical synaptic circuits (Hardingham
and Fox, 2006). Possible reciprocal interactions between NO and
BDNF signaling pathways at the synaptic level are, however, not
well understood.
The importance of NO in the induction and expression
of LTP is supported by numerous studies. Inhibition of NO
generation or genetic deletion of NO synthases (NOS) leads
to reduced LTP in CA1 of the hippocampus (Schuman and
Madison, 1991; Wilson et al., 1997) and the cerebral cortex (Haul
et al., 1999; Volgushev et al., 2000). Endothelial as well as neu-
ronal NOS (eNOS, nNOS) can contribute to hippocampal LTP.
However, the degree to which eNOS and nNOS contribute to
hippocampal LTP is controversial and is critically influenced by
recording and stimulation conditions (compare e.g., Son et al.,
1996; Wilson et al., 1997). Likewise, also the involvement of
NO downstream signaling [e.g., guanylate cyclase, cGMP, pro-
tein kinase G (PKG)] in certain types of LTP relies on the specific
experimental conditions applied (Schuman and Madison, 1994;
Selig et al., 1996; Son et al., 1998; Bon and Garthwaite, 2003;
Neitz et al., 2014). In any case, proper development of NO
dependent hippocampal LTP seems to require phasic and tonic
components of NO generation (Hopper and Garthwaite, 2006).
NOS dependent LTP can be observed especially under condi-
tions of weak synaptic stimulation, whereas more robust high
frequency stimulation can evoke NOS independent LTP (O’Dell
et al., 1994; Wilson et al., 1997). In hippocampal slices, simul-
taneous application of exogenous NO donors during enhanced
synaptic basal stimulation with > 0.1Hz evokes potentiation
(Arancio et al., 1996; Zhuo et al., 1999; Bon and Garthwaite,
2001), and facilitates LTP at otherwise suboptimal stimulation
frequencies (Bon and Garthwaite, 2003), whereas application of
NO alone does not evoke a stable potentiation. Several lines of
evidence suggest that NO acts as a classical retrograde messenger,
that is generated in the postsynaptic neuron upon appropriate
NMDA receptor activation, and travels back to the presynaptic
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neuron to induce enhanced glutamate release (Hardingham et al.,
2013).
The importance of BDNF in hippocampal and neocortical
LTP is also well established. LTP in CA1 and CA3 of the hip-
pocampus, in the visual cortex, and in the amygdala is decreased
under conditions of reduced availability of BDNF (Korte et al.,
1995; Patterson et al., 1996; Kang et al., 1997; Itami et al., 2003;
Abidin et al., 2006; Meis et al., 2012; Schildt et al., 2013). BDNF
is released at synaptic structures upon high-frequency electrical
stimulation (Hartmann et al., 2001) or after firing of theta burst
trains of action potentials (Kuczewski et al., 2008), and medi-
ates pre–and postsynaptic changes of AMPA receptor-mediated
responses, which might both contribute to the maintenance of
LTP (Lessmann et al., 1994; Carmignoto et al., 1997; Lessmann
and Heumann, 1998; Itami et al., 2003). Similar to the role of
NO, the influence of BDNF on LTP in CA1 is critically depen-
dent on details of the LTP stimulation protocol (Kang et al., 1997;
Patterson et al., 2001; Zakharenko et al., 2003).
Given the conjunct importance of NO and BDNF in LTP,
molecular cross talk between the respective signaling cascades
is likely to exist. Previous data indeed suggest an interaction of
both pathways. Upon the one hand, NO production can be stim-
ulated by addition of BDNF (Koh et al., 1995; Samdani et al.,
1997; Klöcker et al., 1998), on the other hand global release of
BDNF from hippocampal slices is inhibited by the NO/cyclic
GMP signaling pathway (Canossa et al., 2002). However, gen-
eration of NO in response to BDNF, and effects of NO on
depolarization-induced synaptic BDNF secretion, have as yet
remained elusive.
Our study now provides evidence, that BDNF induces gen-
eration of NO in hippocampal neurons (somata and dendrites)
on a fast time scale. This NO elevation requires TrkB signaling
and subsequent calcium elevation. We further show that excessive
generation of NO in hippocampal cultures can reduce synaptic
BDNF secretion. However, endogenously released BDNF is not
able to increase intracellular NO levels sufficiently to exert a neg-
ative feedback on BDNF secretion. Thus, the NO-BDNF feedback
loop does not seem to be activated by endogenous levels of BDNF
and NO upon synaptic stimulation.
RESULTS
TIME COURSE AND LOCALIZATION OF BDNF-INDUCED NO SIGNALS IN
NEURONS
BDNF-induced generation of NO in cortical neurons has been
reported previously using DAF imaging (Hwang et al., 2002;
Nott et al., 2008) or quantification of L-arginine consumption
(Riccio et al., 2006). To reveal the location and the time course
of production of endogenous NO in response to exogenously
added BDNF (100 ng/ml) in our hippocampal cells, microcul-
tures of rat hippocampal neurons (15–18DIV) were loaded with
the NO indicator DAF and generation of NO was visualized with
time-lapse confocal microscopy (see Materials and Methods).
Bath application of BDNF-induced an increase of NO that
was evident by the fluorescence increase of DAF (Figures 1A,B).
The increase in DAF fluorescence was detected in all (n = 24
cells from 9 experiments) hippocampal neuronal cultures investi-
gated, but was not observed in co-cultured astrocytes in the same
fields of view. The NO increase became visible within the first
30 s of BDNF application, further increasing in amplitude upon
sustained BDNF stimulation (Figure 1B). On average, somatic
BDNF-induced fluorescence increased roughly 1.5 fold compared
to control levels (at 10min, control: 0.88 ± 0.04, n = 19 hip-
pocampal neurons from 3 experiments; BDNF: 1.41± 0.09, n = 9
cells from 3 experiments). Next we aimed at analysing the time
course of dendritic and somatic NO levels in the same neurons.
In this series of experiments we selected 5 cells in the same field
of view with non-fluctuating DAF signals before and after appli-
cation of BDNF. This experiment revealed BDNF-induced NO
generation concomitantly in soma and dendrites of the identical
hippocampal neurons and the increase was of similar ampli-
tude in both compartments (Figure 1C). As a positive control for
the time course and amplitude of NO signaling in hippocampal
neurons, we applied the NO donor sodium nitroprusside (SNP,
100µM), leading to nearly threefold increase of baseline fluo-
rescence values (at 5min, control: 0.70 ± 0.18%, n = 19; SNP:
2.85 ± 0.28%, n = 9; Figure 1D). Inhibition of NOS by prein-
cubating neurons with L-NMMA (300µM, 30min) completely
blocked the BDNF-induced elevation of intracellular NO lev-
els (Figure 1E). This confirms the specificity of the assay for
the detection of intracellular NO increase (at 10min, control:
100.7 ± 3.8%, n = 7; BDNF: 153.8 ± 9.4%, n = 17; BDNF plus
L-NMMA: 94.1 ± 6.9%, n = 12; L-NMMA: 75.1± 9.1%, n = 7).
A similar degree of inhibition of the BDNF-induced NO signal
was observed when cells were preincubated with the unselec-
tive NO synthase inhibitor L–NAME (10µM) (control: 100.1 ±
4.5%, n = 7; BDNF: 178.6± 12.1%, n = 7, p < 0.001 vs. control;
BDNF plus L-NAME: 100.4± 8.1%, n = 15, p < 0.001 vs. BDNF;
L-NAME: 99.9 ± 5.3%, n = 16).
PHARMACOLOGICAL PROFILE OF BDNF-INDUCED NO GENERATION
To facilitate quantitative analysis of the signaling cascades
involved in BDNF-induced generation of NO, DAF fluorescence
of hippocampal neurons was also determined with a plate reader
assay (see Materials and Methods). Similar to the results obtained
with the confocal microscope, incubation of the cells with BDNF
revealed an NO increase to roughly 150% of control values (at
20min, BDNF: 150 ± 9.6% of control values, p < 0.01 vs. con-
trol; n = 4 independent experiments, Figures 2A,B). The increase
in DAF fluorescence in BDNF treated cells was comparable to the
increase following application of 1µM of the calcium ionophore
ionomycin (at 20min, Ionomycin: 144.3 ± 2.1% of control val-
ues, p < 0.01 vs. control), which served as a positive control in
subsequent experiments. The BDNF-induced NO elevation was
significantly reduced (compare Figures 2A,B) by the NO synthase
inhibitor L–NMMA (300µM; BDNF + L–NMMA: 97.2 ± 2.5%;
L–NMMA: 99.2 ± 0.1% of control values, p < 0.001 vs. BDNF +
L–NMMA), the TrkB receptor kinase inhibitor k252a (200 nM,
30min preincubation; BDNF + k252a: 105.6 ± 6.3%; k252a:
99.2 ± 0.6% of control values, p < 0.001 vs. BDNF + k252a;
n = 4 independent experiments for each treatment, Figure 2B),
and by inhibiting elevation of intracellular Ca2+ by preincubation
with the membrane permeable Ca2+ chelator BAPTA (10mM;
BDNF + BAPTA: 106.3 ± 2.9%; BAPTA: 97.7 ± 1.0% of control
values, p < 0.001 vs. BDNF + BAPTA, Figure 2B). These data
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FIGURE 1 | Time course of BDNF-induced NO signals in hippocampal
neurons. Microcultures of rat hippocampal neurons (15–18DIV) were loaded
with the fluorescent NO indicator DAF, and changes in fluorescence intensity
of DAF were monitored using time-lapse confocal microscopy. (A) Images of
BDNF (100 ng/ml, bath application starting at 0 s)-induced NO signal in a
single hippocampal neuron at time points as indicated. Note the increase of
NO in the soma and proximal dendrites. (B) Average (n = 9 cells from 3
experiments) NO increase induced by bath applied BDNF (100 ng/ml) vs.
negative control (continuously superfused with HBS). Vertical arrow indicates
time point of drug application, ∗p < 0.01. (C) Averaged parallel NO increase in
soma vs. dendrites in the same individual cells (n = 5; different cells than
shown in B). (D) Average (n = 5 cells) NO increase induced by SNP (100µM),
used as positive control, ∗∗p < 0.001 vs. negative control. (E) Mean
BDNF-induced DAF fluorescence intensity 10min after start of stimulation.
Drug application (100 ng/ml BDNF, 300µM L-NMMA, 10µM L-NAME) as
indicated. Note the complete inhibition of BDNF-induced NO signals in the
presence of NOS inhibitors. ∗∗∗p < 0.001 vs. control; ### p < 0.001 BDNF +
L–NAME vs. BDNF. Errors bars represent s.e.m.
indicate, that the BDNF-induced NO increase is mediated via
activation of TrkB receptors, and subsequent intracellular Ca2+
elevation, eventually leading to NO synthase activation.
The neurotrophins NT-3 and NT-4 (100 ng/ml each) also
induced a clear, albeit smaller increase of NO (Figure 2C),
whereas NGF did not lead to a significant NO elevation. These
data indicate that TrkB and TrkC activation can initiate NO sig-
naling in our neurons, with highest efficiency after stimulation of
TrkB with BDNF.
BDNF application is well known to increase neuronal activity
by enhancing synaptic strength (reviewed e.g., in Gottmann et al.,
2009). Due to the relatively slow onset of the BDNF-induced NO
elevation we therefore further investigated whether the observed
NO increase was secondary to enhanced excitatory synaptic activ-
ity in response to BDNF. However, when BDNF was applied
under conditions of complete blockade of glutamatergic synap-
tic transmission (using 10µM DNQX, 50µM APV) no signifi-
cant inhibition of the BDNF-induced NO increase was observed
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FIGURE 2 | Activation of Trk receptors and intracellular Ca2+ elevation
are required for BDNF-induced NO generation. Cultured hippocampal
neurons (15–18DIV) were loaded with the NO indicator DAF, and DAF
fluorescence of wells was monitored with a plate reader. (A) Time course of
average fluorescence intensities (n = 4) is shown for drug treatments (at
1min, 1µM Ionomycin, 300µM L-NMMA) as indicated. (B) Average DAF
fluorescence 20min after treatments as indicated. Ionomycin served as
positive control. ∗p < 0.01 compared with negative control, ∗∗p < 0.001
compared with BDNF positive control. Note the almost complete block of
BDNF-induced NO signals by BAPTA (10µM) and k252a (200 nM). Error bars
represent s.e.m. (C) NO signals induced by BDNF, NGF, NT-3, NT-4,
respectively (100 ng/ml, each; average DAF fluorescence 20min after
treatment as indicated). Note the independence of BDNF-induced NO
signaling from inhibition of glutamatergic transmission (D/APV = 10µM
DNQX, 50µM APV). (D) Inhibition of L–VGCCs with nifedipine (10µM,
average DAF fluorescence after 20min treatment) did not affect
BDNF-induced NO signals. ∗p < 0.05, ∗∗p < 0.01 compared with negative
control. Error bars represents s.e.m.
(Figure 2C). We thus conclude that BDNF-induced NO elevation
in hippocampal neurons occurs independent from enhanced glu-
tamatergic synaptic network activity. Since BDNF-induced NO
elevation was not significantly inhibited in the presence of the
L-type voltage gated calcium channel (VGCC) inhibitor nifedip-
ine (100µM; Figure 2D) we conclude that calcium influx via
L-type VGCC can not account for the calcium increase that
triggers BDNF-induced NO signals.
NO-DEPENDENT MODULATION OF POSTSYNAPTIC RELEASE OF
NEUROTROPHINS
Since previous reports suggested a negative effect of NO signal-
ing on global BDNF secretion from hippocampal slices (Canossa
et al., 2002), we asked whether a similar regulatory effect could
be observed for postsynaptic secretion of BDNF at glutamater-
gic synapses. Cultured hippocampal neurons were cotransfected
at 8–9DIV with PSD-95-DsRed (a postsynaptic marker of glu-
tamatergic synapses) and BDNF-GFP or NT-3-GFP, respectively.
Two days after transfection, postsynaptic clusters of NT contain-
ing secretory granules were identified by colocalization of the
NT-GFP signal with PSD-95-DsRed (Figure 3A). Secretion of
BDNF and NT-3 from postsynaptic sites was induced by appli-
cation of high K+ solution (50mM, 5min) and measured by
analyzing the decrease of intracellular GFP fluorescence inten-
sity using time-lapse video microscopy, as described previously
(Brigadski et al., 2005; see Materials and Methods). Inhibitors of
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FIGURE 3 | Measurement of synaptic release of neurotrophins.
(A) Hippocampal neurons were co-transfected at 8-DIV with BDNF-GFP and
PSD95-DsRed. Co-localization of both proteins was monitored at 10–11DIV.
Boxed areas on the left are shown at higher magnification on the right.
Postsynaptic vesicle clusters of BDNF-GFP (green) were identified by
co-localization with PSD95-DsRed (Red). (B) Time course of postsynaptic
BDNF-GFP and NT-3-GFP release in response to depolarization with elevated
K+ (50mM, 300s). (C) Residual fluorescence of postsynaptic BDNF-GFP and
NT-3-GFP after 300 s depolarization. Experiments were performed in the
presence of 10µM DNQX, 200µM D,L-APV, and 10µM gabazine, to avoid
secondary effects via transmitter secretion. ∗∗p vs control < 0.0001. Error
bars represent s.e.m.
synaptic transmission were added (100µM APV, 10µM DNQX,
50µM Gabazine) to exclude any indirect effects of glutamater-
gic and GABAergic synaptic activity on the secretion process. On
average, this depolarizing stimulation led to a release of about
10% of stored NT content of the secretory vesicles (i.e., remaining
intracellular fluorescence for BDNF-GFP: 91.5 ± 1.3%, n = 19
cells; NT-3: 89.6 ± 1.3%, n = 16 cells; 50mM K+ vs. negative
control significantly different with p < 0.0001; Figures 3B,C).
To elucidate whether the high K+-induced depolarization
used to provoke NT secretion rises intracellular NO levels we
performed DAF-FM imaging (Figure 4A). Bath application of
50mM K+ (10min) induced an increase of intracellular NO in
somata of hippocampal neurons to 141.5± 3.6% (at 500 s follow-
ing stimulation; n = 25) as compared to control (99.5 ± 1.3%;
Figure 4B). This increase was similar in amplitude to BDNF
(100 ng/ml)-induced NO elevation (compare Figures 1, 2), and
was abolished when high K+ solution was applied in the pres-
ence of L-NMMA (300µM; 95.3 ± 2.9%, n = 32; Figure 4B).
Further analysis of short (100–200 s) pulses of high K+ bath
application revealed a concomitant elevation of NO (all values
at 300 s following stimulation) in somata (23.4 ± 6,7%), prox-
imal (13.1 ± 3.6%), and distal dendrites (14.3 ± 5%) without
delay between soma and processes (n = 7, Figures 4C,D,G), sug-
gesting that diffusion of NO from the soma into dendrites of
hippocampal neurons does not account for dendritic NO signals.
When using focal application of depolarizing 50mM K+ solu-
tion via a small diameter pipette (Figure 4E), NO signals could
be elicited selectively in dendrites, demonstrating that dendritic
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FIGURE 4 | Continued
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FIGURE 4 | Somatic vs. dendritic NO signals induced by 50mM
K+-induced stimulation. Hippocampal neurons (10–12DIV) were loaded
with the fluorescent NO indicator DAF-FM, and changes in DAF fluorescence
intensity were monitored using time-lapse video microscopy. (A) Typical
example of DAF-FM loaded hippocampal neurons following stimulation with
50mM K+ used for analysis of fluorescence intensity in the soma as shown
in (B). (B) time course of DAF fluorescence upon stimulation with 50mM
K+ starting at 200 s. Average DAF fluorescence intensity in hippocampal
neurons exposed to 50mM K+ solution under control conditions (n = 25
cells; open circles) and after pre-incubation (10min) in the presence of
300µM L-NMMA (n = 32; black squares). (C,D) Typical DAF-FM loaded
hippocampal neuron with color coded somatic and dendritic regions
analyzed in (D). Note the simultaneous increase in DAF fluorescence in
somatic (red), proximal (green), and distal dendrites (blue). (E) Subcellular
resolution of DAF-FM signals following local pressure-application of high K+
(50mM). High K+ solution was applied via a small pipette (left hand image)
directed toward the dendrite of a hippocampal neuron. The suction pipette
was positioned such that direct depolarization of the soma was avoided.
(F) Normalized DAF fluorescence of color coded regions marked in E
indicates simultaneous NO-generation in dendritic compartments, whereas
no increase was detected in the cell soma. (G) Average peak increase in
DAF fluorescence in 5 independent experiments as shown in (C,D).
(H) Average peak increase in DAF fluorescence in 5 independent
experiments as shown in (E,F). Data represent means ± s.e.m.
NO elevation can occur independent from somatic NO eleva-
tion (n = 6, Figure 4F). On average, local application of high K+
to dendrites caused no significant change in NO levels (1.3 ±
0.5%) in somata, but a simultaneous increase to 15.4 ± 2.1%
in proximal and 24.6 ± 11.6% in distal dendrites (n = 6 cells,
Figure 4H).
We next asked, whether elevation of intracellular levels of
NO can directly initiate the release of NTs. Acute applica-
tion of the NO donor sodium nitroprusside (SNP, 100µM,
10min) alone did not induce release of either BDNF or NT-
3 (remaining intracellular fluorescence for acute SNP: 100.2 ±
0.7%, n = 5; Figure 5B). However, 5min preincubation with
SNP (100µM,) significantly reduced depolarization-induced NT
secretion (BDNF + SNP: 92.9 ± 2.1%, n = 7; BDNF control:
85.2 ± 2.7%, n = 4; NT-3 + SNP: 94.3 ± 1.0%, n = 15; NT-
3 control: 89.4 ± 1.4%, n = 8, p < 0.05; Figures 5 A,B). We
further tested whether inhibition of NOS activity by preincuba-
tion with L–NMMA (300µM, 15min; a concentration effectively
interfering with NO generation by exogenous BDNF and by
high K+, respectively; compare Figures 1, 4) would interfere
with depolarization-induced synaptic neurotrophin secretion.
Interestingly, this paradigm failed to reveal a significant reduc-
tion of either BDNF or NT-3 secretion (BDNF + L-NMMA,
89.7 ± 2.5%, n = 10; BDNF control, 89.7 ± 1.4%, n = 8; NT-
3 + L-NMMA, 92.9 ± 0.8%, n = 7; NT-3 control, 89.5 ± 2.0%,
n = 7, not significantly different with p > 0.05; Figures 5C,D).
This result suggests that the robust depolarization of neurons that
is sufficient to release neurotrophins, did not elevate intracellular
NO up to a level that shows a negative feedback on neurotrophin
secretion.
DISCUSSION
Here we show that BDNF induces NO generation in the soma
and dendrites of hippocampal neurons in a calcium dependent
manner and independently from glutamatergic synaptic activity.
Our time resolved imaging demonstrates that the BDNF-induced
production of NO occurs within 1–2min in dendrites and in
the soma of hippocampal neurons. This NO generation occurred
independent of the enhancing effect of BDNF on glutamater-
gic synaptic activity, but appeared to be a direct consequence of
BDNF/TrkB-induced calcium elevation in the cells. Reciprocally,
strongly enhanced levels of NO inhibit postsynaptic secretion
of BDNF in hippocampal neurons. However, baseline levels of
NO, and levels of NO that were reached in response to high
K+-induced depolarization and subsequent synaptic secretion of
BDNF or NT-3 were below threshold to modulate neurotrophin
secretion.
ACTIVATION OF NOS DOWNSTREAM OF BDNF/TrkB SIGNALING
The finding that BDNF can directly trigger NO production in
hippocampal neurons is in agreement with previous data show-
ing BDNF-induced NO signals in the somata of cultured cortical
neurons (Hwang et al., 2002; Nott et al., 2008), and as shown
indirectly by L-arginine consumption in cortical cultures (Riccio
et al., 2006). Our data now reveal the time course of NO pro-
duction in hippocampal neurons. BDNF-induced NO elevation
can be observed in the soma, as well as in the dendrites within
1–2min following bath application of high concentrations of
BDNF (100 ng/ml). Similarly, high K+-induced depolarization of
the neurons also elicited an intracellular NO increase that was
similar in amplitude and showed a comparable time course as
BDNF-induced NO elevation (compare Figures 1, 4). This high
K+-induced depolarization was further successful in eliciting NT
secretion from our neurons (Figures 3, 5), and is also able to
initiate secretion of endogenous BDNF in hippocampal neurons
(Kuczewski et al., 2008). Although in our release experiments
(i) high K+, (ii) secreted endogenous BDNF, and (iii) secreted
BDNF-GFP, all have the capacity to elevate intracellular NO levels,
this NO elevation was obviously insufficient to reach the thresh-
old for NO dependent modulation of neurotrophin secretion,
that could be observed in the presence of the NO donor SNP
(compare below).
MECHANISM OF BDNF-INDUCED NO ELEVATION
Interestingly, generation of NO in response to BDNF was neither
dependent on AMPA receptor mediated synaptic network activ-
ity, nor on the activation of NMDA receptors, or on the activity
of L-type VGCCs, albeit critically relying on intracellular cal-
cium elevation (compare Figure 2). Thus, our data suggest that
the Ca2+ elevation responsible for NOS activation relies mainly
on calcium release from intracellular stores, as is expected for
BDNF/TrkB signaling (see e.g., Berninger et al., 1993; Marsh
and Palfrey, 1996). This interpretation is also in line with the
slightly delayed onset of NO generation in response to BDNF
(compare Figures 1, 2) which is typical for a second messenger
cascade-induced calcium release from internal stores. It remains
to be shown whether BDNF-induced activation of TRPC3 cal-
cium channels (compare Amaral and Pozzo-Miller, 2007; Nakata
and Nakamura, 2007) also contributes to the BDNF-induced NO
synthesis.
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NT-3 or NT-4 (but not NGF) also induced NO elevation com-
parable in amplitude to BDNF-induced NO signals in our cells.
Hence, our data suggest that TrkB and TrkC (but not TrkA),
signaling are both effective in NO production in our cells. The
absence of TrkA-induced NO elevation might be explained by
the lower abundance of TrkA (compared to TrkB and TrkC) in
cultured hippocampal neurons (Ip et al., 1993). Given the inhibi-
tion of BDNF-induced NO signaling by the Trk kinase inhibitor
k252a, involvement of TrkB signaling in generation of NO seems
warranted.
MODULATION OF NEUROTROPHIN SECRETION BY NO SIGNALING
Our observation that exogenous supply of NO inhibits the secre-
tion of neurotrophins is in line with previous observations
(Canossa et al., 2002). These authors reported that exogenous
application of activators of the cGMP/PKG signaling pathway
decreased basal/spontaneous BDNF secretion similar to NO
donors (Canossa et al., 2002). We now investigated the effect
of NO signaling on depolarization-induced (evoked) secretion
of neurotrophins at glutamatergic synapses, and found that
raising NO levels artificially by a nitric oxide donor (SNP),
showed a similar inhibition of secretion of BDNF and NT-3 in
our assay.
Since the depolarizing stimulus induced by application of
50mM K+ can by itself stimulate NO generation (compare
Figure 4), the most sensitive test for the contribution of endoge-
nously produced NO to modulation of neurotrophin secretion
is application of a NOS inhibitor (L-NMMA, 300µM) during
high K+ depolarization. Importantly, L–NMMA had no effect
on depolarization-induced secretion of BDNF or NT-3 (compare
Figure 5), although the inhibitor was effective in blocking BDNF
as well as high K+-induced generation of NO (Figures 1, 4).
Taken together, these data indicate that the endogenous NO levels
that are reached even by the robust depolarization with 50mM
external K+ are not sufficient to inhibit neurotrophin secretion.
Our finding that inhibition of endogenous baseline NO pro-
duction did not affect neurotrophin secretion is at variance with
previously published results (Canossa et al., 2002). It remains to
be determined whether these contrasting results originate from
differences in experimental procedures, differences in the type of
secretion that was investigated (i.e., global basal secretion from
somata and neurites was investigated by Canossa and coworkers,
FIGURE 5 | NO dependent modulation of synaptic release of BDNF
and NT-3. Hippocampal neurons were transfected with BDNF-GFP
(BDNF) or NT-3-GFP (NT-3) and monitored for neurotrophin secretion.
(A,C) Averaged depolarization-induced (50mM K+) release of NTs vs.
negative control. (B,D) Mean residual fluorescence 300s after stimulation.
(A,B) Preincubation with the NO donor SNP (100µM, 5min) reduced
depolarization-induced secretion of neurotrophins. (C,D) Preincubation and
subsequent superfusion with the NOS inhibitor L–NMMA (300µM, 5min)
during depolarization did not change the amount of neurotrophins that
was released. Experiments were performed in the presence of 10µM
DNQX, 200µM D,L-APV, and 10µM gabazine, to avoid secondary effects
via transmitter secretion. Negative control cells were superfused with
HBS throughout. ∗p vs. control < 0.05, ∗∗p vs control < 0.005. Error
bars represent s.e.m.
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whereas depolarization-induced synaptic secretion was investi-
gated in our present study), or differences in the baseline level
of excitatory synaptic transmission in these two neuronal culture
systems.
CROSSTALK BETWEEN BDNF AND NO SIGNALING
The existence of an interplay between NO and BDNF signaling
has been shown previously for a number of biological effects other
than neurotrophin secretion. Exogenously applied BDNF induces
expression of nNOS and basal expression of NOS is controlled by
the endogenous levels of BDNF (Samdani et al., 1997; Xiong et al.,
1999). In addition, NO synthesis can be stimulated by exogenous
BDNF (Klöcker et al., 1998), and a positive feedback of BDNF
on NO generation can enhance NO-mediated neuronal necrosis
(Koh et al., 1995; Samdani et al., 1997). Finally, BDNF and NO
can promote synergistically neuronal fiber outgrowth (Ernst et al.,
2000). Conversely, NO - apart from negatively regulating BDNF
secretion - exerts mainly a negative regulation of BDNF signaling.
Endogenous NO, presumably released by application of BDNF,
inhibits the neuroprotective effect of BDNF after axotomy of reti-
nal ganglion cells (Klöcker et al., 1998), and NO inhibits BDNF
synthesis in neocortical neurons (Xiong et al., 1999). In contrast,
in vivo studies showed NO-induced increased BDNF production,
which seems to be involved in the formation of spatial memory
(Mizuno et al., 2000). Nevertheless, all these studies investigated
cross talk between both signaling pathways on the time scale of
hours, thus not excluding intermediate secondary effects for this
reciprocal modulation of both signaling cascades. In our study,
using BDNF and NO measurements at higher spatial and time
resolution, and taking into account that we could exclude inter-
mediate synaptic network effects in our measurements, our data
indicate a direct connection of BDNF and NO signaling at the
cellular level.
At the molecular level, there is evidence for a direct posi-
tive interaction between NO and BDNF signaling pathways, as
shown e.g., by the direct activation of TrkB receptors through
NO-induced formation of peroxynitrite (Yuen et al., 2000).
Interestingly, the small G-protein p21ras, which is activated
downstream of TrkB signaling, is a target for S-nitrosylation, giv-
ing potentially rise to NO-induced activation of MAP kinases
(Lander et al., 1996).
Importantly, several studies showed a postsynaptic localization
of both nNOS and TrkB receptors in the postsynaptic density
of glutamatergic synapses of the hippocampus, and nNOS, but
not eNOS, is a component of the NMDA receptor complex (Husi
et al., 2000). In CA1/CA2 of rat hippocampus, NR2A- or NR2B-
containing NMDARs associate with PSD-95, and NR2A coim-
munoprecipitates with nNOS (Al-Hallaq et al., 2007). PSD-95
is necessary for the association of the nNOS/NMDAR complex,
where it associates with both proteins through the second PDZ
domain (Christopherson et al., 1999; Cui et al., 2007). Also other
components of the NO/cGMP/PKG signaling pathway, like e.g.,
the NO-sensitive soluble guanylyl cyclase (sGC) are localized in
part in postsynaptic densities (Burette et al., 2002). Interestingly,
PKG which is a major effector of the NO/sGC/cGMP pathway has
been shown previously in studies in non-neuronal cells, to be per-
missive for regulated exocytosis. (Li et al., 2004; Nanamori et al.,
2007), suggesting a crosstalk between NO signaling and peptide
secretion also outside the central nervous system.
Taken together, these studies suggest a direct interaction of
BDNF and NO signaling pathways in postsynaptic structures,
emphasizing that they can act in concert on synaptic plasticity.
MATERIALS AND METHODS
CELL CULTURE
Dissociated postnatal rat hippocampal microcultures were pre-
pared as described previously (Lessmann and Heumann, 1998;
Brigadski et al., 2005). Primary postnatal rat (P0-P2) neocorti-
cal astrocytes were isolated and cultured for 2–4 weeks in DMEM
medium, containing 10% FCS until expanded to confluence.
Astrocytes were passaged and seeded on glass cover slips at a
density of 80.000 cells per 3.5 cm dish in DMEM/10% FCS, to
yield astrocyte islands of 100–300µm in diameter after 7–14 days
in vitro (DIV). Five µM ARAC was added 5 days after seeding of
astrocytes to avoid further growth of astrocyte islands. For single-
cell time-lapse measurements, dissociated postnatal rat (P0–P2)
hippocampal neurons were plated in DMEM/10% FCS at a den-
sity of 1–10 neurons per astrocyte island onto the astrocyte cover
slips.
For measurement of NO signals with a plate reader, dissoci-
ated rat hippocampal neurons were plated in DMEM/10% FCS at
a density of 30–60.000 neurons per well in poly-ornithine coated
96 wellplates. After 20 h the plating medium was exchanged
to serum-free medium (Neurobasal with 2% B27 supplement,
Invitrogen).
TRANSFECTION
Rat hippocampal microcultures were transfected with the respec-
tive expression plasmids (3µg DNA per 3.5 cm dish) at 8–9DIV,
using the Ca2+ phosphate precipitation method as described pre-
viously (Haubensak et al., 1998). During incubation (1.5–3 h),
10µM DNQX and 100µM D,L-APV were added to reduce exci-
totoxicity. After one to two hours the transfection medium was
replaced, cultures were washed 3 times with warmed HBS, and
the cultures were kept in neuron-conditioned Neurobasal/B27
medium, thereafter. The cells were used for time lapse imaging
experiments 1–3 days after transfection.
COTRANSFECTION WITH SYNAPTIC MARKER PROTEINS
The construction and use of the PSD95-DsRed expression plas-
mid was described previously (Brigadski et al., 2005). Intact
synaptic targeting of PSD95-DsRed was confirmed by colocal-
ization of PSD95-DsRed with the green fluorescent activity-
dependent label of active synapses, FM 1–43 (data not shown).
To identify postsynaptic structures, in BDNF-GFP and NT-3-GFP
expressing hippocampal neurons, cells were cotransfected with
the respective NT-GFP construct together with PSD95-DsRed
(DNA ratio GFP:DsRed, 1:1, 3µg per dish overall).
EPIFLUORESCENCE IMAGING
Visualization of epifluorescence signals was performed as
described previously (Hartmann et al., 2001). Briefly, cover
slips with transfected cells were transferred into Petriperm
dishes (Vivascience) with folio bottom and inspected with an
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inverted microscope (Olympus IX70) using 40 × (N.A.: 1.0)
and 100 × (N.A.: 1.35) oil immersion objectives. Image cap-
ture was performed using a cooled CCD camera (Sensys 1401E,
Photometrics), controlled by MetaVue software (Molecular
Devices). Exposure times were chosen such that saturation was
avoided. Processing of images was performed by MetaVue and
Adobe Photoshop software without compromising the evident
primary image information. However, in the figures, fluorescence
in the soma and the proximal dendrites is often enhanced close to
saturation in order to make single vesicles in distal neurites also
clearly visible.
Some of the experiments were performed using an upright
microscope (Zeiss, Axioscope FS) equipped with a 40 × objec-
tive (Olympus, LumPlanFI, N.A. 0.8 w). DAF-FM fluorescence
was exited at 485 nm with a VisiChrome high speed monochro-
mator (Visitron, Puchheim, Germany). Fluorescence images were
taken with a Photometrics CoolSnap HQ2 CCD camera (Roper
Scientific) at 0.1Hz after passing a 510 nm long pass filter. Image
acquisition and analysis was performed using Metafluor software
(Molecular Devices).
CONFOCAL IMAGING
Analysis of the subcellular distribution of DAF fluorescence sig-
nals was performed with a Nipkow spinning disk confocal sys-
tem (Visitech, England) attached to a conventional fluorescence
microscope (Olympus BX51 WI) equipped with a high aperture
water immersion objective (60×, n.A. 0.9). Full frame image cap-
ture was performed with a cooled CCD camera (CoolSnap HQ,
Roper Scientific). Green and red fluorescence was excited with the
488 nm and the 568 nm lines, respectively, of a Kr/Ar laser (Laser
Physics, U.S.). Image capture and analysis was performed using
Metamorph software (Molecular Devices).
MEASUREMENT OF INTRACELLULAR NO LEVELS
Rat hippocampal neurons were incubated 30min in Neurobasal
medium at 37◦C with diaminofluoresceine (DAF, 100µM). The
cells were washed once with HEPES buffered saline (HBS:
100mM NaCl, 4mM KCl, 20mM HEPES, 0.9mM Na2HPO4,
2mM CaCl, 1mM MgCl2, 10mM glucose, 0.01mM glycine, pH
7.4). Then the cells were preincubated 15–20min at 37◦C with
inhibitors and used subsequently for single cell time-lapse record-
ing of DAF fluorescence with a Nipkow spinning disk confocal
microscope (excitation at 488 nm; emission apps 500–550 nm).
For some of the experiments cultured hippocampal neurons
(10–12DIV) were incubated with DAF-FM (10µM) for 60min in
HBS buffer at 35◦C. After dye loading, coverslips were transferred
to the experimental chamber and washed for 15min with fresh
HBS. During experiments, cells were constantly superfused with
fresh HBS.
For analyzing DAF fluorescence in 96 well plates, measure-
ments were performed with an Infinite™ 200 plate reader at 37◦C
(Tecan, Germany, excitation at 485 nm). The cells were stimulated
6min after the beginning of measurement. For each condition,
the data were normalized to the mean value obtained during the
preincubation time. Measurements not showing a stable baseline
in the absence of stimulation during the first 6min of recording,
were excluded from analysis.
MEASUREMENT OF NEUROTROPHIN RELEASE
Real time imaging of synaptic secretion of GFP-tagged NTs was
performed by analyzing the decrease of intracellular GFP fluo-
rescence, as described previously (Brigadski et al., 2005). Cells
with synaptically localized NT-GFP were superfused locally with
HBS throughout the experiment, and images were captured at
10 s intervals. After 5min control period, cells were depolar-
ized (5min) by superfusing 50mM K+ containing (replacing an
equal amount of Na+) HBS at RT. Regions with synaptic clus-
ters of NT-GFP were analyzed. Background fluorescence levels of
a void region in the same field of view was recorded in parallel
and subtracted. Fluorescence decrease due to photobleaching was
corrected for by extrapolating the fluorescence decrease during
an initial 5min control period over the whole recording time.
Original fluorescence values at a given time point were normal-
ized to the corresponding value of this extrapolated bleaching
curve, thus providing a measure of the fluorescence decrease,
which is due to release. This fluorescence decrease has been shown
previously to reflect tetanus toxin and Ca2+ sensitive release of
NTs (see Hartmann et al., 2001).
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